Replies to post #209076 on Biotech Values

[DewDiligence]

AVIR implements “strategic review”—market yawns:

http://finance.yahoo.com/news/aviragen-therapeutics-announces-review-strategic-100000113.html

If the intent was to boost the share price for a financing, it didn’t work.